Actively Recruiting
De-implementation of Overuse of Mammography Screening in Older Racially and Ethnically Diverse Women
Led by Columbia University · Updated on 2026-04-06
500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
C
Columbia University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying a new approach to reduce unnecessary screening mammograms in women aged 75 and older. This trial focuses on decreasing overuse of mammography, which may cause more harm than benefit in older women due to factors like shorter life expectancy and risks from follow-up procedures. The study aims to test a multilevel strategy involving patients, providers, and healthcare organizations to better align mammography use with current guidelines and patient needs. The study compares two groups: one receiving enhanced usual care with organizational support such as provider education and consensus-building task forces, and another receiving this plus additional provider and patient interventions. Providers in the intervention group receive educational newsletters, and patients receive a brochure encouraging discussions with their providers about the appropriateness of continuing mammograms. Organizational components apply to all participants across selected clinics. Participants will be monitored for 18 months to assess screening mammography overuse, provider ordering behavior, and mammography screening discussions. Data will be collected through scheduled primary care visits and healthcare records. The study involves a cluster randomized controlled design at the provider level and includes diverse older women. Safety and study outcomes will be tracked throughout the trial period.
CONDITIONS
Brief Title
A Multi-Level Strategy for De-implementing Mammography Overuse Among Older Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- English- or Spanish-speaking women based on preferred language in electronic health record
- Women aged 75 years or older at the time of their scheduled primary care visit
- Women with a primary care visit scheduled within the next 2 to 4 weeks
- Women who have not had a screening mammogram in the 6 months before their scheduled primary care visit but had one 7 to 18 months prior
You will not qualify if you...
- Women with a history of atypical ductal hyperplasia or non-invasive or invasive breast cancer
- Women with dementia
- Women with ICD codes indicating breast cancer, dementia, or related conditions (F01-F03, Z85.3, G30-G31, N60, C50, or D05)
- Primary care clinicians who are specialists, treat patients under 18 years old, are non-clinicians, or physician assistants
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 18 months
Participants receive either enhanced usual care involving organizational level strategies or a multilevel de-implementation strategy including provider and patient educational components aimed at reducing mammography overuse.
Visits occur during routine primary care appointments over 18 months
Trial Site Locations
Total: 1 location
1
Columbia University Irving Medical Center
New York, New York, United States, 10032
Actively Recruiting
Research Team
P
Parisa Tehranifar, DrPH
A
Anita G Karr, MPH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here